VitroScan featured in the latest edition of BiotechNews

21 May 2026

Excited to see VitroScan featured in the latest edition of BiotechNews!

The article highlights our mission to advance precision oncology through predictive ex vivo micro-tumor testing, helping physicians and their patients make better informed treatment decisions. It also features a duo interview with our CEO Willemijn Vader and Project Steering Committee chair Joris Schuurmans on the journey of the ChemoPredict project. Their conversation highlights how close collaboration between innovators, clinical experts, and experienced entrepreneurs helps accelerate the path from science to patient impact.

With the support of Biotech Booster, whose CBO Marco De Boer (Ph.D., MBA) was also featured in the article, the ChemoPredict project is moving forward to bring predictive chemotherapy response testing closer to clinical implementation for ovarian cancer patients.

👉 Full article: https://lnkd.in/eaNzJhNT